Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Healthcare AI company Suki has closed a $90M Series E round to expand its AI capabilities beyond ambient documentation. The company, which now partners with 250+ health systems, envisions a unified AI platform spanning clinical, financial, and operational workflows. It also just launched "Ask," a clinical decision support tool powered by Wolters Kluwer's UpToDate Expert AI.
Healthcare AI company Suki has raised $90 million in Series E funding, with backing from new investors Healthier Capital, Crosslink Capital, and Hercules Capital, alongside existing investors including Venrock and Philips Ventures. The fresh capital will go toward advancing Suki's AI technology, growing its commercial team, and scaling its partner ecosystem.
CEO Punit Soni says the company's ambition goes well beyond AI-assisted documentation — the goal is to build a "connected, intelligent operating system for healthcare" that ties together clinical, financial, and operational workflows. Rather than adding yet another point solution to an already fragmented landscape, Suki wants to serve as the foundational infrastructure through which best-in-class AI tools work seamlessly together.
Alongside the funding news, Suki launched "Ask," a new clinical decision support feature that lets clinicians query Wolters Kluwer's UpToDate Expert AI directly within the Suki for Clinicians app — the first product integration of the UpToDate Expert AI API.
By the Numbers:
Why it matters: As health systems grapple with AI tool sprawl, Suki's push toward an integrated AI platform signals a broader industry shift — from isolated automation to system-wide intelligence that could meaningfully reduce clinician burden and improve care delivery.
